Skip to main content
. 2015 Oct 17;34:123. doi: 10.1186/s13046-015-0241-7

Fig. 2.

Fig. 2

Graph showing the percentage of EpCAM positive viable cell in patients’ pleura exudate after 7 days incubation with control BiTE® vs solitomab. EpCAM (p = 2.09378E-06); MT201/P1 (p = 0.001724101) significant difference